Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
CP: Immunology
ILC1
TGF-β
cirrhotic liver
cross-tissue ILC1
human group 1 ILC
innate lymphoid cell
liver ILC1
liver environment
natural killer cell
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
31 01 2023
31 01 2023
Historique:
received:
22
03
2021
revised:
30
09
2022
accepted:
15
12
2022
pubmed:
15
1
2023
medline:
7
2
2023
entrez:
14
1
2023
Statut:
ppublish
Résumé
Group 1 innate lymphoid cells (ILCs) comprise a heterogeneous family of cytotoxic natural killer (NK) cells and ILC1s. We identify a population of "liver-type" ILC1s with transcriptional, phenotypic, and functional features distinct from those of conventional and liver-resident NK cells as well as from other previously described human ILC1 subsets. LT-ILC1s are CD49a
Identifiants
pubmed: 36640314
pii: S2211-1247(22)01838-1
doi: 10.1016/j.celrep.2022.111937
pmc: PMC9950534
mid: NIHMS1870503
pii:
doi:
Substances chimiques
Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111937Subventions
Organisme : NCI NIH HHS
ID : L30 CA199447
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255860
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA208353
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145997
Pays : United States
Organisme : NCI NIH HHS
ID : F30 CA250244
Pays : United States
Organisme : NCI NIH HHS
ID : F30 CA236063
Pays : United States
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.
Références
FEBS Lett. 2001 Jul 27;502(1-2):1-3
pubmed: 11478937
Front Immunol. 2019 Sep 11;10:2180
pubmed: 31572388
Nat Commun. 2021 Oct 6;12(1):5841
pubmed: 34615883
Immunity. 2019 Feb 19;50(2):505-519.e4
pubmed: 30770247
Gut. 2019 May;68(5):916-927
pubmed: 29970455
Immunity. 2017 May 16;46(5):756-757
pubmed: 28514676
Blood. 2014 Jul 31;124(5):700-9
pubmed: 24778151
Gut. 2022 Jun;71(6):1161-1175
pubmed: 34340996
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Immunity. 2010 Jun 25;32(6):803-14
pubmed: 20620944
Nat Protoc. 2021 Aug;16(8):3802-3835
pubmed: 34215862
Nat Immunol. 2013 Mar;14(3):221-9
pubmed: 23334791
Sci Immunol. 2022 Apr 8;7(70):eabi8642
pubmed: 35394814
Cell Rep. 2016 Jul 12;16(2):379-391
pubmed: 27373165
Front Immunol. 2019 Jun 04;10:1255
pubmed: 31214196
Nat Immunol. 2011 Sep 11;12(11):1055-62
pubmed: 21909091
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
Mol Ecol Resour. 2013 Jul;13(4):663-73
pubmed: 23617785
Immunity. 2016 May 17;44(5):1127-39
pubmed: 27156386
Elife. 2019 Aug 08;8:
pubmed: 31393266
Sci Rep. 2016 May 23;6:26157
pubmed: 27210614
Immunity. 2017 May 16;46(5):758-759
pubmed: 28514677
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34183415
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
Front Immunol. 2019 Sep 20;10:2235
pubmed: 31616419
Front Immunol. 2019 Apr 30;10:946
pubmed: 31114585
Gut. 2007 Feb;56(2):243-52
pubmed: 16840505
Front Immunol. 2019 Aug 29;10:2078
pubmed: 31555287
PLoS One. 2017 Dec 19;12(12):e0188649
pubmed: 29261670
Eur J Immunol. 2017 Aug;47(8):1280-1294
pubmed: 28613415
Immunity. 2018 Sep 18;49(3):464-476.e4
pubmed: 30193847
Front Immunol. 2019 Jul 03;10:1502
pubmed: 31333651
Nature. 2009 Feb 5;457(7230):722-5
pubmed: 18978771
Elife. 2014 Jan 01;3:e01659
pubmed: 24714492
Front Immunol. 2016 Jan 07;6:646
pubmed: 27004067
PLoS Pathog. 2017 May 15;13(5):e1006373
pubmed: 28505204
Sci Rep. 2015 Jul 30;5:12490
pubmed: 26223896
Blood Adv. 2019 Nov 26;3(22):3674-3687
pubmed: 31765481
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
J Hepatol. 2018 Sep;69(3):654-665
pubmed: 29758330
Cancer Immunol Res. 2019 Sep;7(9):1535-1546
pubmed: 31311791
Front Immunol. 2012 Apr 09;3:72
pubmed: 22566953
Sci Rep. 2017 Mar 13;7:44356
pubmed: 28287163
Trends Immunol. 2019 Oct;40(10):909-921
pubmed: 31500958
J Immunol. 2016 Jul 1;197(1):78-84
pubmed: 27226093
Elife. 2021 Feb 08;10:
pubmed: 33554861
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Immunity. 2017 Jan 17;46(1):148-161
pubmed: 27986455
PLoS One. 2016 Jul 25;11(7):e0159217
pubmed: 27454769
Signal Transduct Target Ther. 2017;2:
pubmed: 29201496
Immunity. 2021 Feb 9;54(2):276-290.e5
pubmed: 33434494
Nat Immunol. 2017 Sep;18(9):1004-1015
pubmed: 28759001
Nature. 2019 Apr;568(7752):405-409
pubmed: 30944470
Nat Immunol. 2009 Jan;10(1):66-74
pubmed: 19029905
Sci Immunol. 2020 Oct 16;5(52):
pubmed: 33067380